Frazier Life Sciences Acquisition Corp. II (FLSC)
CIK 2153598 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Frazier Life Sciences Acquisition Corp. II.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Oct 27, 2026 | SCHEDULE 13G | 0001738048-26-000075 |
| Oct 22, 2026 | SCHEDULE 13G | 0001346824-26-000245 |
| Oct 22, 2026 | 8-K | 0001193125-26-429129 |
| Oct 21, 2026 | SCHEDULE 13G | 0000921895-26-002836 |
| Oct 21, 2026 | SCHEDULE 13G | 0001172661-26-004630 |
| Oct 21, 2026 | SCHEDULE 13D | 0001193125-26-428005 |
| Oct 16, 2026 | SCHEDULE 13G | 0001104659-26-116496 |
| Oct 15, 2026 | 4 | 0001193125-26-422957 |
| Oct 15, 2026 | 8-K | 0001193125-26-422919 |
| Oct 14, 2026 | 424B4 | 0001193125-26-421735 |
| Oct 13, 2026 | EFFECT | 9999999995-26-003227 |
| Oct 13, 2026 | 3 | 0001193125-26-420790 |
| Oct 13, 2026 | 3 | 0001193125-26-420812 |
| Oct 13, 2026 | CERT | 0001354457-26-000983 |
| Oct 13, 2026 | 3 | 0001193125-26-420801 |
| Oct 13, 2026 | 3 | 0001193125-26-420782 |
| Oct 13, 2026 | 3 | 0001193125-26-420791 |
| Oct 13, 2026 | 3 | 0001193125-26-420796 |
| Oct 13, 2026 | 3 | 0001193125-26-420789 |
| Oct 8, 2026 | 8-A12B | 0001193125-26-417909 |
| Sep 24, 2026 | S-1 | 0001193125-26-399703 |